$NHC
NATIONAL HEALTHCARE CORP

2016 Q3 Form 10-Q Financial Statement

#000104733516000260 Filed on November 03, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q3
Revenue $231.3M $225.4M
YoY Change 2.62% 3.28%
Cost Of Revenue $140.4M $135.1M
YoY Change 3.92% 4.81%
Gross Profit $90.90M $90.30M
YoY Change 0.66% 1.12%
Gross Profit Margin 39.3% 40.06%
Selling, General & Admin $10.30M $10.00M
YoY Change 3.0% 1.01%
% of Gross Profit 11.33% 11.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.00M $9.200M
YoY Change 8.7% 6.98%
% of Gross Profit 11.0% 10.19%
Operating Expenses $79.30M $75.90M
YoY Change 4.48% 2.57%
Operating Profit $10.59M $13.76M
YoY Change -23.04% -6.62%
Interest Expense $1.020M $594.0K
YoY Change 71.72% -6.01%
% of Operating Profit 9.63% 4.32%
Other Income/Expense, Net $5.091M $4.550M
YoY Change 11.89% 15.57%
Pretax Income $15.68M $18.31M
YoY Change -14.36% -1.94%
Income Tax $4.571M $5.744M
% Of Pretax Income 29.15% 31.37%
Net Earnings $11.11M $12.57M
YoY Change -11.59% -2.04%
Net Earnings / Revenue 4.8% 5.58%
Basic Earnings Per Share $0.73 $0.75
Diluted Earnings Per Share $0.73 $0.72
COMMON SHARES
Basic Shares Outstanding 15.20M 13.80M
Diluted Shares Outstanding 15.22M 14.42M

Balance Sheet

Concept 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $166.2M $181.3M
YoY Change -8.33% -2.21%
Cash & Equivalents $19.21M $70.78M
Short-Term Investments $147.0M $110.6M
Other Short-Term Assets $30.50M $29.30M
YoY Change 4.1% 11.83%
Inventory $7.446M $7.566M
Prepaid Expenses
Receivables $76.65M $81.85M
Other Receivables $6.400M $5.500M
Total Short-Term Assets $287.2M $305.6M
YoY Change -6.01% 2.27%
LONG-TERM ASSETS
Property, Plant & Equipment $557.7M $526.3M
YoY Change 5.97% 3.72%
Goodwill $17.60M $17.60M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $36.60M $34.90M
YoY Change 4.87% -0.85%
Other Assets $243.5M $250.4M
YoY Change -2.79% 46.2%
Total Long-Term Assets $801.1M $776.7M
YoY Change 3.14% 4.37%
TOTAL ASSETS
Total Short-Term Assets $287.2M $305.6M
Total Long-Term Assets $801.1M $776.7M
Total Assets $1.088B $1.082B
YoY Change 0.56% 3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.40M $16.10M
YoY Change 8.07% 18.38%
Accrued Expenses $78.10M $86.00M
YoY Change -9.19% 9.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.400M $3.200M
YoY Change 6.25% 6.67%
Total Short-Term Liabilities $142.8M $180.7M
YoY Change -20.97% 8.65%
LONG-TERM LIABILITIES
Long-Term Debt $120.0M $10.00M
YoY Change 1100.0% -77.43%
Other Long-Term Liabilities $16.21M $16.74M
YoY Change -3.15% -86.3%
Total Long-Term Liabilities $136.2M $26.74M
YoY Change 409.44% -83.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $142.8M $180.7M
Total Long-Term Liabilities $136.2M $26.74M
Total Liabilities $279.0M $207.4M
YoY Change 34.51% -37.69%
SHAREHOLDERS EQUITY
Retained Earnings $384.9M $359.4M
YoY Change 7.1%
Common Stock $152.0K $143.0K
YoY Change 6.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $670.8M $746.4M
YoY Change
Total Liabilities & Shareholders Equity $1.088B $1.082B
YoY Change 0.56% 3.77%

Cashflow Statement

Concept 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income $11.11M $12.57M
YoY Change -11.59% -2.04%
Depreciation, Depletion And Amortization $10.00M $9.200M
YoY Change 8.7% 6.98%
Cash From Operating Activities $18.40M $23.10M
YoY Change -20.35% -25.24%
INVESTING ACTIVITIES
Capital Expenditures -$14.40M -$16.00M
YoY Change -10.0% 16.79%
Acquisitions
YoY Change
Other Investing Activities -$5.800M -$2.200M
YoY Change 163.64% 100.0%
Cash From Investing Activities -$20.20M -$18.10M
YoY Change 11.6% 21.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -16.00M -5.800M
YoY Change 175.86% -61.07%
NET CHANGE
Cash From Operating Activities 18.40M 23.10M
Cash From Investing Activities -20.20M -18.10M
Cash From Financing Activities -16.00M -5.800M
Net Change In Cash -17.80M -800.0K
YoY Change 2125.0% -172.73%
FREE CASH FLOW
Cash From Operating Activities $18.40M $23.10M
Capital Expenditures -$14.40M -$16.00M
Free Cash Flow $32.80M $39.10M
YoY Change -16.11% -12.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
nhc Increase Decrease In Due To Third Party Payors
IncreaseDecreaseInDueToThirdPartyPayors
2353000
nhc Increase Decrease In Due To Third Party Payors
IncreaseDecreaseInDueToThirdPartyPayors
3480000
nhc Annual Excess Coverage
AnnualExcessCoverage
7500000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
nhc Annual Excess Coverage
AnnualExcessCoverage
4000000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
nhc Direct Business Coverage Statutory Limits
DirectBusinessCoverageStatutoryLimits
1000000
CY2016Q3 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1892000
CY2015Q3 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1588000
nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
5654000
nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
5093000
CY2016Q3 nhc Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount
EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount
1306000
CY2015Q3 nhc Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount
EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount
1715000
nhc Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount
EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount
1306000
nhc Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Amount
EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsAmount
1715000
CY2016Q3 nhc Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Percent
EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsPercent
0.083
CY2015Q3 nhc Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Percent
EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsPercent
0.094
nhc Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Percent
EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsPercent
0.023
nhc Effective Income Tax Rate Reconciliation Benefit Resulting From Expiration Of Applicable Statute Limitations Percent
EffectiveIncomeTaxRateReconciliationBenefitResultingFromExpirationOfApplicableStatuteLimitationsPercent
0.029
CY2016Q3 nhc Number Of Assisted Living Facilities
NumberOfAssistedLivingFacilities
21
CY2016Q3 nhc Number Of Beds
NumberOfBeds
9398
CY2016Q3 nhc Number Of Homecare Programs
NumberOfHomecarePrograms
36
CY2016Q3 nhc Number Of Independent Living Facilities
NumberOfIndependentLivingFacilities
5
CY2016Q3 nhc Number Of Nursing Facilities Under Medicaid Cost Report Audits
NumberOfNursingFacilitiesUnderMedicaidCostReportAudits
11
CY2016Q3 nhc Number Of Skilled Nursing Centers
NumberOfSkilledNursingCenters
74
nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
-1134000
nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
585000
CY2015Q2 nhc Stock Repurchase Program Number Of Plans
StockRepurchaseProgramNumberOfPlans
2
CY2016Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
19007000
CY2015Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
16654000
CY2016Q3 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
3440000
CY2015Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
3440000
CY2016Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
17359000
CY2015Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
20128000
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76654000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
84095000
CY2016Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
50579000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
65338000
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
363831000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
339241000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
75063000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
53364000
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
210710000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
209469000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
585000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-1134000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1557000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
502000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
425000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
502000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1557000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8059000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5583000
CY2016Q3 us-gaap Assets
Assets
1088355000
CY2015Q4 us-gaap Assets
Assets
1045329000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
287230000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
278942000
CY2016Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
175763000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
171174000
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
325903000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
286034000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
120218000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
86921000
CY2016Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
254000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2237000
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
205939000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
201350000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
73505000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
71442000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
75474000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
70223000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
81710000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
74747000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
82810000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
74671000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
2018000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1694000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
2021000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
1699000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
18530000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
23291000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
18581000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
23273000
CY2016Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
178886000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
169866000
CY2016Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
6817000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
5200000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70781000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18996000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1014000
CY2016Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2016Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3429000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3279000
CY2016Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
27638000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
30228000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
38567000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
5200000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5200000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
5200000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5200000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
12567000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
7500000
CY2016Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
31067000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38208000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69767000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19212000
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.30
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.14
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15149239
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15000616
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15149239
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15000616
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
152000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
150000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14276000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8472000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58374000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24579000
CY2016Q3 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3440000
CY2015Q4 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3440000
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
220691000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
211625000
us-gaap Costs And Expenses
CostsAndExpenses
645782000
us-gaap Costs And Expenses
CostsAndExpenses
625792000
CY2016Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4152000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3315000
CY2016Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
23587000
CY2015Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
9096000
CY2016Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8170000
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8451000
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9998000
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9273000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
28847000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
27442000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28847000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27442000
us-gaap Dividends Common Stock
DividendsCommonStock
16256000
us-gaap Dividends Common Stock
DividendsCommonStock
19798000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
392766000
CY2016Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10314000
CY2015Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10006000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
30960000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
29972000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21638000
CY2016Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4206000
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3203000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2769000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.21
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.291
CY2015Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.314
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.364
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.362
CY2015Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
5996000
CY2016Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
CY2015Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2152000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
us-gaap Dividends Preferred Stock
DividendsPreferredStock
6487000
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.30
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.41
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7163000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6488000
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
804000
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
449000
CY2016Q3 us-gaap Goodwill
Goodwill
17600000
CY2015Q4 us-gaap Goodwill
Goodwill
17600000
CY2016Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
12634000
CY2015Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
10035000
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
35397000
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
30850000
CY2016Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
218647000
CY2015Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
215351000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
653240000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
641845000
CY2016Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
231281000
CY2015Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
225386000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
688637000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
672695000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
15681000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
18311000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
57644000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
59805000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4926000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3924000
CY2016Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1806000
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1538000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4571000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5744000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20969000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
230000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1667000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8485000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-14759000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-575000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-196000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-11000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-909000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4795000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
837000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
770000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
253000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
486000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1003000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4114000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-122000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
439000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4981000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2674000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-84000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
726000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
704000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
228000
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-9455000
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-7423000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
15507000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
8897000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
471020
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
64522
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
430856
CY2016Q3 us-gaap Interest Expense
InterestExpense
1020000
CY2015Q3 us-gaap Interest Expense
InterestExpense
594000
us-gaap Interest Expense
InterestExpense
2913000
us-gaap Interest Expense
InterestExpense
1782000
CY2016Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1393000
CY2015Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1424000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4209000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3885000
CY2016Q3 us-gaap Inventory Net
InventoryNet
7446000
CY2015Q4 us-gaap Inventory Net
InventoryNet
7568000
CY2016Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
36574000
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
37683000
CY2016Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
140403000
CY2015Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
135136000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
405491000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1088355000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1045329000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
142802000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
150656000
CY2016Q3 us-gaap Long Term Debt
LongTermDebt
120000000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
120000000
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
120000000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
120000000
CY2016Q3 us-gaap Malpractice Loss Contingency Number Of Claims
MalpracticeLossContingencyNumberOfClaims
35
CY2016Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
147017000
CY2015Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
116168000
CY2016Q3 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
12571000
CY2015Q4 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
18276000
CY2016Q3 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
166315000
CY2015Q4 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
151590000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20619000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14877000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47651000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47439000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49274000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63330000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
11110000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
12567000
us-gaap Net Income Loss
NetIncomeLoss
36675000
us-gaap Net Income Loss
NetIncomeLoss
38167000
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11110000
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10415000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36675000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
31680000
CY2016Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2253000
CY2015Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
460000
CY2016Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
12639000
CY2015Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
12704000
CY2016Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
10
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
10590000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
13761000
us-gaap Operating Income Loss
OperatingIncomeLoss
42855000
us-gaap Operating Income Loss
OperatingIncomeLoss
46903000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
356300000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
34200000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
34200000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
34200000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
34200000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
34200000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
185300000
CY2016Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9669000
CY2015Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
9865000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
243460000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230341000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13588000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
21699000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3166000
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4095000
CY2016Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
264000
CY2015Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
28000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
804000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
449000
CY2016Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2028000
CY2015Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-2657000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
13582000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-8670000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
5458000
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-6724000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
36085000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-21809000
CY2016Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
58956000
CY2015Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
56616000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
177571000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
173830000
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18044000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12192000
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16210000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16294000
CY2016Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5091000
CY2015Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4550000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
14789000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
12902000
CY2016Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
12634000
CY2015Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
10035000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
35397000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
30850000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2015 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8195000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18977000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15367000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6502000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
1282000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
373000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2419000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
5477000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50466000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38953000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
34747000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
49993000
CY2016Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2015Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2152000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6487000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2875000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2171000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
845000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
333000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10070000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8231000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
30963000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
2299000
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
14996000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
39601000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
30963000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
39601000
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
921496000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
875287000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
557665000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
536046000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5774000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5474000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
804000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
449000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
2440000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8793000
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2162000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2313000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
384890000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
368013000
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">D</div><div style="display: inline; font-style: italic;">eferred Revenue </div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"></div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (&#x201c;National&#x201d;), the non-refundable portion</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> (10%) of CCRC entrance fees being amortized over the remaining life expectancies of the residents, and premiums received within our workers&#x2019; compensation and professional liability companies that are not yet earned. </div></div></div></div></div></div>
CY2015Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
27069000
CY2016Q3 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
70042000
CY2015Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
71439000
CY2016Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
97609000
CY2015Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
98508000
CY2016Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
27567000
us-gaap Share Based Compensation
ShareBasedCompensation
502000
us-gaap Share Based Compensation
ShareBasedCompensation
1557000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.031
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.158
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.165
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
185459
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
55.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
656
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.69
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.92
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.15
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56210
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56774
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2062000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
954678
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
621390
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
197233
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
55.55
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
47.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
46.81
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.47
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
62.53
CY2016Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
197233
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y73D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y73D
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2010000
CY2016Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
55.55
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y255D
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
389498
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
480275
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8231000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10070000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-8195000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
734148000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
746357000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
630996000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
670815000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Estimates and Assumptions</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div></div></div></div>
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15222648
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14422660
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15216838
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14365251
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15198696
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13801245
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15128728
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13778705

Files In Submission

Name View Source Status
0001047335-16-000260-index-headers.html Edgar Link pending
0001047335-16-000260-index.html Edgar Link pending
0001047335-16-000260.txt Edgar Link pending
0001047335-16-000260-xbrl.zip Edgar Link pending
exhibit311adams.htm Edgar Link pending
exhibit312daniel.htm Edgar Link pending
exhibit32nhc.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nhc-20160930.xml Edgar Link completed
nhc-20160930.xsd Edgar Link pending
nhc-20160930_cal.xml Edgar Link unprocessable
nhc-20160930_def.xml Edgar Link unprocessable
nhc-20160930_lab.xml Edgar Link unprocessable
nhc-20160930_pre.xml Edgar Link unprocessable
nhcseptember2016form10q.htm Edgar Link pending
nhcseptember2016form10q001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending